http://www.onemedplace.com/blog/wp-content/uploads/2009/04/stemcells.jpg
President Obama’s recent reversal of Bush's policy on embryonic stem cell research reignited the debate over the ethical limits of science. However, as the Wall Street Journal reports, an innovative...
View Articlehttp://www.onemedplace.com/blog/wp-content/uploads/2009/08/depressed.jpg
Acadia and its partner Biovail made news last month with a failed late-stage trial of pimavanserin, their experimental drug candidate to treat psychosis related to Parkinson's disease.
View Articlehttp://www.onemedplace.com/blog/wp-content/uploads/2010/04/pills.jpg
It was good news for Novartis and bad news for Merck KGaA this week as regulators handed down their decisions on each company’s multiple sclerosis (MS) drug candidate.
View Article
More Pages to Explore .....
